Insulin injection positioning patch
The design of the insulin injection positioning patch utilizes navel positioning and erasable sealing film markings to solve the problem of the positioning card needing to be repositioned, thereby achieving accuracy in insulin injection and tissue protection and simplifying the operating process.
Patent Information
- Application Number
- CN202521503247.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-17
- Publication Date
- 2025-09-05
- Estimated Expiration
- 2035-07-17
AI Technical Summary
Existing positioning cards need to be repositioned for each injection, resulting in inaccurate positioning and easily leading to repeated injections in the same location, affecting insulin absorption rate and tissue health.
An insulin injection positioning patch was designed, which includes a navel positioning hole and multiple injection holes. It is adhered to the skin for a long time through an adhesive layer, and an erasable sealing film is used to mark the used holes. Arrows are set to indicate the injection path to achieve accurate positioning and avoid repeated injections.
Ensure accurate positioning of each injection, avoid repeated injections in the same location, improve the stability of insulin absorption, protect subcutaneous tissue, simplify the operation process, and reduce the risk of fat hyperplasia.
Smart Images

Figure CN223299394U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of subcutaneous injection auxiliary tools, in particular to an insulin injection positioning patch. Background Art
[0002] Correct insulin injection includes standardized rotation of injection sites. Irregular or even no rotation of injection sites will result in frequent insulin stimulation of tissues, which will cause cell edema and metabolic disorders, and produce chemical stimulation to local tissues. Mechanical damage caused by frequent injections will damage, degenerate, and atrophy muscle fibers, leading to subcutaneous fat hyperplasia. Since the insulin absorption rate in the fat hyperplasia area is reduced, patients often need to inject more doses of insulin to achieve equivalent blood sugar control levels. At the same time, due to the instability of the insulin absorption rate in the hyperplasia area, the variability of insulin efficacy increases, and the patient's blood sugar fluctuations increase, leading to unstable blood sugar.
[0003] To prevent repeated injections at the same site, tools such as positioning cards are often used in clinical practice. However, positioning cards are only used during injections and are easily lost when not in use. Furthermore, positioning cards need to be repositioned for each injection, and human skin is often an irregular surface with no obvious indicators, which can lead to positioning errors and repeated injections at the same site. Utility Model Content
[0004] The purpose of this utility model is to solve the technical problem that existing positioning cards need to be repositioned for each injection, resulting in inconsistent positioning each time and inaccurate positioning, which can easily lead to repeated injections at the same location. The utility model provides an insulin injection positioning patch that does not require repositioning for each injection, can accurately position the insulin and avoid repeated injections at the same location.
[0005] In order to solve the above technical problems, an embodiment of the present utility model discloses an insulin injection positioning patch, including a positioning patch body, the positioning patch body including: a navel positioning hole, used to align with the human navel; a plurality of injection holes, arranged around the navel positioning hole, and spaced apart from the navel positioning hole; an erasable sealing film is provided in each of the injection holes; a connecting part, including an area on the positioning patch body where the navel positioning hole is not provided and an area where the injection hole is not provided; an adhesive layer is provided on one surface of the connecting part along the thickness direction of the positioning patch body, and the adhesive layer is used to stick the positioning patch body to the skin.
[0006] Using the above technical solution, the insulin injection positioning patch is aligned with the navel through the navel positioning hole to achieve rapid positioning. By providing an adhesive layer, the positioning patch body is adhered to the skin, ensuring that the positioning patch body can be attached to the human body for a long time, so that there is no need to use the insulin injection positioning patch to reposition before each injection, thereby ensuring the accuracy of positioning for multiple injections. The injection hole with an erasable sealing film set around the navel positioning hole needs to be erased before injection. The medical staff or patient then directly inserts the needle of the syringe through the injection hole into the part of the human body corresponding to the injection hole. This ensures that the injection sites are evenly distributed to avoid repeated injections, and the used hole sites are visually marked with the erasable sealing film, further avoiding repeated injections in the same area, and ultimately achieving precise rotation management of injection sites and protection of subcutaneous tissue.
[0007] According to another specific embodiment of the present invention, the erasable sealing film includes a water-soluble polymer film.
[0008] By adopting the above technical solution, the water-soluble polymer film dissolves immediately when exposed to physiological saline, so that it can be safely removed by simply wiping with a cotton swab, simplifying the use process while ensuring hygienic sealing.
[0009] According to another specific embodiment of the present invention, the positioning patch body includes two injection areas, which are respectively located on both sides of the navel positioning hole, and each injection area includes a plurality of injection holes.
[0010] By adopting the above technical solution, double injection areas are set on both sides of the navel positioning hole. Each injection area contains multiple injection holes to form a bilateral balanced injection network. The double injection area design is ergonomic, convenient for alternating operation between the left and right hands, and can achieve symmetrical rotation of injection sites.
[0011] According to another specific embodiment of the present invention, the multiple injection holes in each injection area define an injection path, and along the extension direction of the injection path, an arrow mark is provided between two adjacent injection holes, and the arrow mark is used to indicate the direction from the previous injection hole to the next injection hole.
[0012] By adopting the above technical solution, arrow marks are set between two adjacent injection holes to connect multiple injection holes in the same injection area, forming a unidirectional injection path, thereby achieving sequential and orderly injection between the multiple injection holes.
[0013] According to another specific embodiment of the present invention, the positioning sticker body is circular, polygonal or irregular in shape.
[0014] According to another specific embodiment of the present invention, the navel positioning hole and the injection hole are both circular. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 A three-dimensional diagram showing an insulin injection positioning patch according to an embodiment of the present utility model;
[0016] Figure 2 A schematic diagram showing an embodiment of the insulin injection positioning patch of the present utility model being attached to human skin;
[0017] Figure 3 A schematic diagram showing an adhesive layer provided on the connecting portion of an embodiment of the present invention is shown. DETAILED DESCRIPTION
[0018] The following is an explanation of the implementation of the present invention by means of specific specific embodiments. Those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. Although the description of the present invention will be introduced in conjunction with the preferred embodiment, this does not mean that the features of this utility model are limited to this implementation. On the contrary, the purpose of introducing the utility model in conjunction with the implementation is to cover other options or modifications that may be extended based on the claims of the present invention. In order to provide an in-depth understanding of the present invention, the following description will contain many specific details. The present invention can also be implemented without using these details. In addition, in order to avoid confusion or blurring the focus of the present invention, some specific details will be omitted in the description. It should be noted that, in the absence of conflict, the embodiments of the present invention and the features in the embodiments can be combined with each other.
[0019] It should be noted that in this specification, similar reference numerals and letters denote similar items in the following drawings, and therefore, once an item is defined in one drawing, it does not need to be further defined or explained in subsequent drawings.
[0020] In the description of this embodiment, it should be noted that the terms "upper", "lower", "inner", "bottom", etc. indicate orientations or positional relationships based on the orientations or positional relationships shown in the accompanying drawings, or are the orientations or positional relationships in which the utility model product is usually placed when in use. They are only for the convenience of describing the utility model and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation. Therefore, they cannot be understood as a limitation on the utility model.
[0021] The terms “first”, “second”, etc. are only used for distinguishing descriptions and should not be understood as indicating or implying relative importance.
[0022] In the description of this embodiment, it should be noted that, unless otherwise specified or limited, the terms "disposed," "connected," and "connected" should be understood broadly. For example, they can refer to fixed connections, detachable connections, or integral connections; mechanical connections or electrical connections; direct connections or indirect connections through an intermediate medium; and internal connections between two components. Those skilled in the art will understand the specific meanings of the above terms in this embodiment based on specific circumstances.
[0023] In order to make the purpose, technical solutions and advantages of the present invention more clear, the embodiments of the present invention will be described in further detail below with reference to the accompanying drawings.
[0024] refer to Figure 1 and Figure 2 The present invention provides an insulin injection locating patch 100, comprising a locating patch body 200, wherein the locating patch body 200 includes a navel locating hole 300, a plurality of injection holes 400, and a connecting portion 500. The navel locating hole 300 is used to align with the navel 10 of the human body, thereby enabling rapid and accurate centering of the insulin injection locating patch 100.
[0025] like Figure 1 As shown, two injection areas 401 are located on either side of the navel positioning hole 300, each with multiple injection holes 401. Specifically, the multiple injection holes 400 are arranged around the navel positioning hole 300 and spaced apart from it. Each injection hole 400 is sealed with a removable film (not shown). It is understood that, provided the navel positioning hole 300 is aligned with the navel 10, the area of the body corresponding to the injection hole 400 is the ideal location for insulin injection.
[0026] For example, each injection area 401 is provided with 20 injection holes 400. However, those skilled in the art will appreciate that in other embodiments, each injection area 401 may also be provided with other numbers of injection holes 400, such as 16, 24, and so on.
[0027] In this embodiment, the erasable sealing film comprises a water-soluble polymer film. The water-soluble polymer film dissolves immediately when exposed to physiological saline, allowing safe removal with just a cotton swab, thus simplifying the use process while ensuring hygienic sealing.
[0028] In this embodiment, the navel positioning hole 300 and the injection hole 400 are both circular. However, those skilled in the art will appreciate that in other embodiments, the navel positioning hole 300 and the injection hole 400 may also be in other shapes, such as rectangular, elliptical, etc. The shapes of the navel positioning hole 300 and the injection hole 400 may be the same or different, and this application does not impose any limitation thereto.
[0029] like Figure 2 and Figure 3 As shown, the connecting portion 500 includes an area on the positioning patch body 200 that is not provided with the navel positioning hole 300 and the injection hole 400; along the thickness direction of the positioning patch body 200, one surface 501 of the connecting portion 500 is provided with an adhesive layer 600, and the adhesive layer 600 is used to adhere the positioning patch body 200 to the skin. In other words, the surface of the positioning patch body 200 that faces the human skin and avoids the navel positioning hole 300 and the injection hole 400 is provided with an adhesive layer 600. The connecting portion 500 achieves a stable fit between the positioning patch body 200 and the skin through the adhesive layer 600, ensuring that the positioning patch body 200 can be attached to the human body for a long time, avoiding the problems of traditional positioning cards being easily lost and the positioning patch body 200 changing position during multiple injections; at the same time, the connecting portion 500 serves as a transition structure to the non-functional area, maintaining the integrity and flexibility of the positioning patch body 200 without interfering with the precise use of the navel positioning hole 300 and the injection hole 400, thereby effectively preventing repeated injections in the same position while simplifying the operating process.
[0030] In this embodiment, the positioning patch body 200 is an irregularly shaped sheet structure, and the navel positioning hole 300 and the injection hole 400 are both through holes provided through the positioning patch body 200. Those skilled in the art will appreciate that in other embodiments, the positioning patch body 200 may also have other shapes, such as a circle, a polygon, etc.
[0031] Using the above technical solution, refer to Figures 1 to 3 The insulin injection positioning patch 100 is aligned with the navel 10 through the navel positioning hole 300 to achieve rapid positioning, and the positioning patch body 200 is attached to the skin by providing an adhesive layer 600, ensuring that the positioning patch body 200 can be attached to the human body for a long time, so that there is no need to use the insulin injection positioning patch 100 to reposition before each injection, thereby ensuring the accuracy of positioning for multiple injections. Injection holes 400 with erasable sealing films are provided on both sides of the navel positioning hole 300. The erasable sealing films need to be erased before injection, and then the medical staff or the patient directly injects the needle of the syringe through the injection hole 400 into the part of the human body corresponding to the injection hole 400, thereby ensuring that the injection sites are evenly distributed to avoid repeated injections, and the used holes are visually marked by the erasable sealing films, further avoiding repeated injections in the same part, and ultimately achieving accurate rotation management of injection sites and protection of subcutaneous tissue.
[0032] It is understood that the two injection areas 401 of the insulin injection patch 100 of this embodiment have a total of 40 injection holes 400. Therefore, after 40 injections are completed, each injection hole 400 has been used and the erasable sealing film inside all injection holes 400 has been erased. Before the next injection, the insulin injection patch 100 can be removed and a new insulin injection patch 100 can be attached to the skin for the next round of injections.
[0033] like Figure 1 As shown, in this embodiment, the multiple injection holes 400 in each injection area 401 define an injection path. Along the extension direction of the injection path, an arrow mark 402 is provided between two adjacent injection holes 400. The arrow mark 402 is used to indicate the direction from the previous injection hole 400 to the next injection hole 400. In other words, by providing an arrow mark 402 between two adjacent injection holes 400, this embodiment connects the multiple injection holes 400 located in the same injection area 401, forming a unidirectional injection path, and realizing sequential and orderly injection between the multiple injection holes 400.
[0034] That is, this embodiment forms a guided rotation system by setting a directional injection path with an arrow mark 402 in each injection area 401. The arrow clearly indicates the advancement direction of adjacent injection holes 400. The patient only needs to use it in sequence to automatically achieve a scientific interval distribution of injection sites. The path design ensures uniform drug absorption of subcutaneous tissue, effectively reduces the risk of fat hyperplasia, simplifies the operation process, and significantly improves the standardization and convenience of injection management.
[0035] Although the present invention has been illustrated and described with reference to certain preferred embodiments of the present invention, it should be understood by those skilled in the art that the above description is provided to further illustrate the present invention in conjunction with specific embodiments, and that the present invention should not be construed as being limited to these descriptions. Those skilled in the art may make various changes in form and detail, including simple deductions or substitutions, without departing from the spirit and scope of the present invention.
Claims
1. An insulin injection positioning patch, characterized in that: The positioning sticker body includes: Navel positioning hole, used to align with the human navel; A plurality of injection holes are arranged around the navel positioning hole and spaced apart from the navel positioning hole; each injection hole is provided with an erasable sealing film; The connecting portion includes an area on the positioning patch body that is not provided with the navel positioning hole and the injection hole; along the thickness direction of the positioning patch body, one surface of the connecting portion is provided with an adhesive layer, and the adhesive layer is used to stick the positioning patch body to the skin.
2. The insulin injection positioning patch according to claim 1, characterized in that: The erasable sealing film includes a water-soluble polymer film.
3. The insulin injection positioning patch according to claim 1, characterized in that: The positioning patch body includes two injection areas, which are respectively located on both sides of the navel positioning hole, and each injection area includes a plurality of injection holes.
4. The insulin injection positioning patch according to claim 3, characterized in that: The multiple injection holes in each injection area define an injection path. Along the extension direction of the injection path, an arrow mark is provided between two adjacent injection holes, and the arrow mark is used to indicate the direction from the previous injection hole to the next injection hole.
5. The insulin injection positioning patch according to claim 3, characterized in that: The positioning sticker body is in a circular, polygonal or irregular shape.
6. The insulin injection positioning patch according to claim 5, characterized in that: The navel positioning hole and the injection hole are both circular.